JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 864 JPY -1.1% Market Closed
Market Cap: 252.6B JPY
Have any thoughts about
JMDC Inc?
Write Note

JMDC Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

JMDC Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
JMDC Inc
TSE:4483
Other Long-Term Assets
ÂĄ2.2B
CAGR 3-Years
8%
CAGR 5-Years
33%
CAGR 10-Years
N/A
M3 Inc
TSE:2413
Other Long-Term Assets
ÂĄ14.3B
CAGR 3-Years
53%
CAGR 5-Years
21%
CAGR 10-Years
32%
EM Systems Co Ltd
TSE:4820
Other Long-Term Assets
ÂĄ1B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
5%
S
Software Service Inc
TSE:3733
Other Long-Term Assets
ÂĄ833.6m
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
20%
Medley Inc
TSE:4480
Other Long-Term Assets
ÂĄ1.2B
CAGR 3-Years
30%
CAGR 5-Years
35%
CAGR 10-Years
N/A
e
eWeLL Co Ltd
TSE:5038
Other Long-Term Assets
ÂĄ134.9m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

JMDC Inc
Glance View

Market Cap
252.5B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
3 587.97 JPY
Overvaluation 7%
Intrinsic Value
Price

See Also

What is JMDC Inc's Other Long-Term Assets?
Other Long-Term Assets
2.2B JPY

Based on the financial report for Sep 30, 2024, JMDC Inc's Other Long-Term Assets amounts to 2.2B JPY.

What is JMDC Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
33%

Over the last year, the Other Long-Term Assets growth was 0%. The average annual Other Long-Term Assets growth rates for JMDC Inc have been 8% over the past three years , 33% over the past five years .

Back to Top